PaccmannRL: Designing Anticancer Drugs From Transcriptomic Data via Reinforcement Learning

19Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The pharmaceutical industry has experienced a significant productivity decline: Less than 0.01% of drug candidates obtain market approval, with an estimated 10–15 years until market release and costs that range between one [2] to three billion dollars per drug [3].

Cite

CITATION STYLE

APA

Born, J., Manica, M., Oskooei, A., Cadow, J., & Rodríguez Martínez, M. (2020). PaccmannRL: Designing Anticancer Drugs From Transcriptomic Data via Reinforcement Learning. In Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) (Vol. 12074 LNBI, pp. 231–233). Springer. https://doi.org/10.1007/978-3-030-45257-5_18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free